ARG70216
SARS-CoV-2 nucleocapsid recombinant protein (His-SUMO tagged, N-ter)
SARS-CoV-2 nucleocapsid recombinant protein (His-SUMO tagged, N-ter) for SDS-PAGE and Virus
Overview
| Product Description | HEK293 expressed, His-SUMO tagged (N-ter) SARS-CoV-2 nucleocapsid recombinant protein. |
|---|---|
| Tested Reactivity | Virus |
| Tested Application | SDS-PAGE |
| Target Name | SARS-CoV-2 nucleocapsid protein |
| Species | Virus |
| A.A. Sequence | MSDNG PQNQR NAPRI TFGGP SDSTG SNQNG ERSGA RSKQR RPQGL PNNTA SWFTA LTQHG KEDLK FPRGQ GVPIN TNSSP DDQIG YYRRA TRRIR GGDGK MKDLS PRWYF YYLGT GPEAG LPYGA NKDGI IWVAT EGALN TPKDH IGTRN PANNA AIVLQ LPQGT TLPKG FYAEG SRGGS QASSR SSSRS RNSSR NSTPG SSRGT SPARM AGNGG DAALA LLLLD RLNQL ESKMS GKGQQ QQGQT VTKKS AAEAS KKPRQ KRTAT KAYNV TQAFG RRGPE QTQGN FGDQE LIRQG TDYKH WPQIA QFAPS ASAFF GMSRI GMEVT PSGTW LTYTG AIKLD DKDPN FKDQV ILLNK HIDAY KTFPP TEPKK DKKKK ADETQ ALPQR QKKQQ TVTLL PAADL DDFSK QLQQS MSSAD STQA with polyhistidine-SUMO tag at the N-terminus. |
| Expression System | HEK293 |
Properties
| Form | Powder |
|---|---|
| Purification | Ni-NTA chromatography. |
| Purification Note | Endotoxin level is less than 0.1 EU/µg of the protein, as determined by the LAL test. |
| Purity | > 98% (by SDS-PAGE) |
| Buffer | PBS (pH 7.4) |
| Reconstitution | It is recommended to reconstitute the lyophilized protein in sterile water to a concentration not less than 100 µg/ml and incubate the stock solution for at least 20 min at room temperature to make sure the protein is dissolved completely. |
| Storage Instruction | Lyophilized protein should be stored at -20°C. After reconstitution, aliquot and store at -20°C or -80°C for up to one month. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. |
| Note | For laboratory research only, not for drug, diagnostic or other use. |
Bioinformation
| Highlight | Related products: SARS-CoV antibodies; SARS-CoV ELISA Kits; SARS-CoV recombinant proteins; Related news: HMGB1, a biomarker and therapeutic target in COVID-19 Exploring Antiviral Immune Response |
|---|
